Far From Rare: A Common Disease Hidden in Plain Sight Why ME/CFS Needs to be Recognized Now February often brings conversations about rare diseases—conditions affecting fewer than 200,000 people in the U.S. ME/CFS doesn’t fit that definition. Yet, we chose to...
The emergence of SARS-CoV-2, the virus responsible for COVID-19, swept across the globe with an unparalleled speed and severity. As a researcher dedicated to understanding how viral infections lead to chronic illness, I knew this pandemic would have far-reaching...
Promising Clinical Trial Results: Advancing ME/CFS and Long COVID Treatment by Suzanne Vernon, PhD, Director of Research At the Bateman Horne Center (BHC), we are committed to finding effective treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)...
Practical Tools for Managing ME/CFS: Insights from Amy Mooney, MS OTR/L and caregiver Caring for a teenager with severe ME/CFS has been a life-changing journey for me, both as a mother and as an occupational therapist. The complexities of this condition—where energy...
Celebrating a Decade of Excellence: In March 2025, the Bateman Horne Center of Excellence (BHC) will mark a milestone: its tenth anniversary. Over the past 10 years, BHC has become a premier resource for individuals affected by ME/CFS, Long COVID and other...
Innovative Trials: Research and Clinical Insights on Long COVID Therapy Candace Rond, Bateman Horne Center's Research Manager and Jennifer Bell Clinical Manager and Medical Provider The Research In the summer of 2022, the Bateman Horne Center (BHC) carried out an...
Reflections on the 2024 Mast Cell Masterminds Conference By Melanie Hoppers, M.D. Last month, I had the opportunity to attend the 2024 Mast Cell Masterminds Conference in Oregon with my Bateman Horne Center colleagues, Dr. Brayden Yellman and Jennifer Bell, FNP-C....
Living with Orthostatic Intolerance (OI) by Melanie Hoppers, MD If you’ve ever felt like simple, everyday activities drain your energy, you’re not alone. Living with orthostatic intolerance (OI) can turn activities like standing in line, taking a shower, or even...
The Story Behind "Life with a Low Battery: Living with ME/CFS" I am thrilled to announce the release of our latest educational video, Life with a Low Battery: Living with ME/CFS. This video was created not just to educate, but to amplify the voices of those...
Many people are unfamiliar with the use of low dose naltrexone (LDN) other than as regular dosed naltrexone which is used to support individuals with addiction recovery. However, at much lower doses it can be useful for people with ME/CFS, Long COVID, mast cell...
Far From Rare: A Common Disease Hidden in Plain Sight Why ME/CFS Needs to be Recognized Now February often brings conversations about rare diseases—conditions affecting fewer than 200,000 people in the U.S. ME/CFS doesn’t fit that definition. Yet, we chose to...
The emergence of SARS-CoV-2, the virus responsible for COVID-19, swept across the globe with an unparalleled speed and severity. As a researcher dedicated to understanding how viral infections lead to chronic illness, I knew this pandemic would have far-reaching...
Promising Clinical Trial Results: Advancing ME/CFS and Long COVID Treatment by Suzanne Vernon, PhD, Director of Research At the Bateman Horne Center (BHC), we are committed to finding effective treatments for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)...
Practical Tools for Managing ME/CFS: Insights from Amy Mooney, MS OTR/L and caregiver Caring for a teenager with severe ME/CFS has been a life-changing journey for me, both as a mother and as an occupational therapist. The complexities of this condition—where energy...
Celebrating a Decade of Excellence: In March 2025, the Bateman Horne Center of Excellence (BHC) will mark a milestone: its tenth anniversary. Over the past 10 years, BHC has become a premier resource for individuals affected by ME/CFS, Long COVID and other...
Innovative Trials: Research and Clinical Insights on Long COVID Therapy Candace Rond, Bateman Horne Center's Research Manager and Jennifer Bell Clinical Manager and Medical Provider The Research In the summer of 2022, the Bateman Horne Center (BHC) carried out an...
Reflections on the 2024 Mast Cell Masterminds Conference By Melanie Hoppers, M.D. Last month, I had the opportunity to attend the 2024 Mast Cell Masterminds Conference in Oregon with my Bateman Horne Center colleagues, Dr. Brayden Yellman and Jennifer Bell, FNP-C....
Living with Orthostatic Intolerance (OI) by Melanie Hoppers, MD If you’ve ever felt like simple, everyday activities drain your energy, you’re not alone. Living with orthostatic intolerance (OI) can turn activities like standing in line, taking a shower, or even...
The Story Behind "Life with a Low Battery: Living with ME/CFS" I am thrilled to announce the release of our latest educational video, Life with a Low Battery: Living with ME/CFS. This video was created not just to educate, but to amplify the voices of those...
Many people are unfamiliar with the use of low dose naltrexone (LDN) other than as regular dosed naltrexone which is used to support individuals with addiction recovery. However, at much lower doses it can be useful for people with ME/CFS, Long COVID, mast cell...
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career - the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.